LEHI, Utah, March 11, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases ...
LEHI, Utah, March 11, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases, announced ...
Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases, announced that it has been awarded the Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback